Products
Zolera
Pharmacotherapeutic group
agents for the treatment of bone diseases; agents affecting bone structure and mineralization; bisphosphonatesInternational name
Zoledronic acidDosage form
concentrate for preparation of solution for infusionBone resorption inhibitor, nitrogen-containing bisphosphonate. Acts mainly on bone, inhibits the activity of osteoclasts and bone resorption. In addition to its inhibitory effect on bone resorption, zoledronic acid has antitumor properties, which ensure the drug's efficacy in bone metastases.